Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis

Haematologica

Volumn 100, Issue 5, 2015, Pages 565-567

  Tolosano, Emanuela ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOTRANSFERRIN; CD71 ANTIGEN; ERYTHROFERRONE; HAPTOGLOBIN; HEMOPEXIN; HEPCIDIN; PROTEIN; RECOMBINANT PROTEIN; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG; APOPROTEIN; HEMOGLOBIN BETA CHAIN; TRANSFERRIN;

BETA THALASSEMIA; DYSERYTHROPOIESIS; EDITORIAL; HUMAN; IRON OVERLOAD; MYOCARDIAL DISEASE; SICKLE CELL ANEMIA; TRANSFERRIN BLOOD LEVEL; ANIMAL; FEMALE; GENE DELETION; GENETICS; HEMOCHROMATOSIS; MALE; PATHOLOGY;

ANIMALS; APOPROTEINS; BETA-GLOBINS; FEMALE; GENE DELETION; HEMOCHROMATOSIS; MALE; TRANSFERRIN;

EID: 84929192537     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.124966     Document Type: Editorial

References (19)

1. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24-38.
2. Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem. 1999;274(30):20826-20832.
3. Silvestri L, Nai A, Pagani A, Camaschella C. The extrahepatic role of TFR2 in iron homeostasis. Front Pharmacol. 2014;5:93.
4. Worthen CA, Enns CA. The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body. Front Pharmacol. 2014;5:34.
5. Lane DJ, Merlot AM, Huang ML, et al. Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease. Biochim Biophys Acta. 2015;1853(5):1130-1144.
6. Ginzburg Y, Rivella S. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood. 2011;118(16):4321-4330.
7. Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med. 2010;16(2):177-182.
8. Gelderman MP, Baek JH, Yalamanoglu A, et al. Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous b1/b2 globin gene deletion) mice. Haematologica. 2015;100(5):611-622.
9. Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest. 2010;120(12):4466-4477.
10. Bartnikas TB, Andrews NC, Fleming MD. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood. 2011;117(2):630-637.
11. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-1741.
12. Babitt JL, Lin HY. The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis. 2011;31(3):280-292.
13. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014;46(7):678-684.
14. Nai A, Lidonnici MR, Rausa M, et al. The second transferrin receptor regulates red blood cell production in mice. Blood. 2015;125(7):1170-1179.
15. Forejtnikovà H, Vieillevoye M, Zermati Y, et al. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood. 2010;116(24):5357-5367.
16. Pagani A, Vieillevoye M, Nai A, et al. Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form. Haematologica. 2015;100(4):458-465.
17. Chiabrando D, Vinchi F, Fiorito V, Mercurio S, Tolosano E. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front Pharmacol. 2014;5:61.
18. Vinchi F, De Franceschi L, Ghigo A, et al. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Circulation. 2013;127(12):1317-1329.
19. Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front Physiol. 2014 2014;5:415.